Asploro Journal of Biomedical and Clinical Case Reports
![Asploro Journal of Biomedical and Clinical Case Reports [ISSN: 2582-0370]](https://i0.wp.com/asploro.com/wp-content/uploads/2023/11/Asploro-Journal-of-Biomedical-and-Clinical-Case-Reports-2024.jpg?resize=853%2C1024&ssl=1)
ISSN: 2582-0370
Article Type: Case Report
DOI: 10.36502/2024/ASJBCCR.6367
Asp Biomed Clin Case Rep. 2024 Aug 19;7(3):226-32
Abel Ning Caballero1iD*, Kandecy Archer-Austin1iD
1Oncology Department, Georgetown Public Hospital Corporation, Guyana
Corresponding Author: Abel Ning Caballero ORCID iD
Address: Guyana Public Hospital Corporation, Georgetown, Guyana.
Received date: 17 July 2024; Accepted date: 12 August 2024; Published date: 19 August 2024
Citation: Caballero AN, Archer-Austin K. Hepatoblastoma: A Case Report. Asp Biomed Clin Case Rep. 2024 Aug 19;7(3):226-32.
Copyright © 2024 Caballero AN, Archer-Austin K. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
Keywords: Hepatoblastoma, Liver Tumor, Hepatectomy
Abstract
Hepatoblastoma is a rare type of pediatric malignant disease and represents the most frequent cause of liver tumors during childhood. We describe the diagnosis and treatment of a 14-month-old female patient who presented with abdominal swelling, anorexia, and weight loss. Initial investigations indicated elevated alpha-fetoprotein levels and thrombocytosis. A CT scan showed a heterogeneous mass arising in the right lobe of the liver. Histology revealed hepatoblastoma, epithelial type, and fetal pattern. The patient was treated as a standard risk according to the Pretext classification (Pretext I-III) with neoadjuvant Cisplatin (4 cycles) following the SIOPEL 3 protocol, resulting in a 40% reduction in tumor size and a successful partial hepatectomy.
